Treatment of fecal incontinence

Details Treatment of fecal incontinence Treatment of fecal incontinence

1998-08-11

2000-12-05

Travers, Russell

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514415, A61K 41415, A61K 31405

Patent

active

061567809

ABSTRACT:
The present invention relates to a treatment for patients having fecal incontinence by administering a composition comprising histamine, serotonin or a combination thereof in an amount effective to alleviate symptoms of fecal incontinence.

REFERENCES:
patent: 4689222 (1987-08-01), McMichael
patent: 4692332 (1987-09-01), McMichael
patent: 4877610 (1989-10-01), McMichael
patent: 4880626 (1989-11-01), McMichael
patent: 4966753 (1990-10-01), McMichael
patent: 4970071 (1990-11-01), McMichael
patent: 5576289 (1996-11-01), McMichael
patent: 5610174 (1997-03-01), Craig et al.
patent: 5877198 (1999-03-01), McMichael
Medline abstract, AN 86137670, Goldberg, M. et al., Jan. 1986.
HCAPLUS abstract, AN 1995:494721, abstract of WO 9506466 A1, Mar. 1995.
Goodman Gilman et al. The Pharmaeological Basis of Therapeutics (6.sup.th Ed.), New York: MacMillan, p. 517, 1980.
Castex, N. et al., Gastroenterol. Clin. Biol., vol. 17, pp. 478-84, (France), 1993.
Bueno et al., European Journal of Pharmacology: 192, 263-269 (1991).
Castex et al., Role of Serotonin and Histamine in Colonic Motility and Transit Disturbances Induced by Mast Cell Degranulation: an Experimental Study in the Rat, Laboratoire de Pharmacologie-Toxicologie, INRA, 180, chemin de Tournefeuille, BP 3, F-31931 Toulouse Cedex (translation).
Fargeas et al., J. Pharm. Pharmacol.: 41, 534-540 (1989).
Fargeas et al., Gastroenterology: 102, 157-162 (1992).
Scott, "Mediation of food protein-induced jejunal smooth muscle contraction in sensitized rats," Gastrointestinal Research Group, University of Calgary, Calgary, Alberta T2N 4N1, Canada.
Database HCAPLUS on STN, American Chemical Society, AN 1994:75356, Castex, N. et al., "Role of serotonin and histamine in colonic motility and transit disturbances induced by mast cell degranulation: An experimental study in the rat," Gastroenterol. Clin. Biol., 17(6-7):478-484 (1993) (Abstract).
Physician's Desk Reference.RTM., PDR, 51 Edition 1997, Sansert.RTM. methysergide maleate tablets, pp. 2424-2425 (1997).
Gagar et al., "The effects of Bay K 8644 on agonist-induced contractions in guinea pig urinary bladder," Acta Pharm. Jugosl. 41(3):211-216 (1991).
Harrison's Principles of Internal Medicine, Thirteenth Edition, Isselbacher, K.J. et al. (Eds.), pp. 240-241 (1994).
Database HCAPLUS on STN American Chemical Society, AN: 1991:671268; DN: 115: 271268; Gacar, N. et al., "The effects of Bay K 8644 on agonist-induced contractions in guinea pig urinary bladder," Acta Pharm. Jugosl. 41(3):211-216 (1991) (Abstract).
Database HCAPLUS on STN American Chemical Society, AN: 1989:547237; DN: 111: 147237; Yoshinaga, M. et al., "Responsiveness of the isolated and regional preparations of cat vesicourethral system to automatic nervous system-related endogenous agents," Yakuri to Chiryo (JP), 17(5):2049-2055 (1989) (Abstract).

Affiliated with

Also associated with

Rating

Treatment of fecal incontinence does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of fecal incontinence, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of fecal incontinence will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-962146